Acadian Asset Management LLC Reduces Stake in Kewaunee Scientific Co. (NASDAQ:KEQU)

Acadian Asset Management LLC lessened its position in shares of Kewaunee Scientific Co. (NASDAQ:KEQU) by 11.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 6,483 shares of the technology company’s stock after selling 834 shares during the quarter. Acadian Asset Management LLC’s holdings in Kewaunee Scientific were worth $100,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of KEQU. Dimensional Fund Advisors LP increased its position in shares of Kewaunee Scientific by 0.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 185,989 shares of the technology company’s stock valued at $3,273,000 after purchasing an additional 742 shares during the last quarter. Minerva Advisors LLC grew its position in Kewaunee Scientific by 1.4% during the first quarter. Minerva Advisors LLC now owns 172,919 shares of the technology company’s stock valued at $2,730,000 after buying an additional 2,378 shares during the period. Vanguard Group Inc. increased its holdings in Kewaunee Scientific by 1.3% during the first quarter. Vanguard Group Inc. now owns 126,581 shares of the technology company’s stock valued at $1,836,000 after buying an additional 1,683 shares during the last quarter. Finally, Renaissance Technologies LLC raised its position in Kewaunee Scientific by 0.7% in the second quarter. Renaissance Technologies LLC now owns 98,111 shares of the technology company’s stock worth $1,631,000 after acquiring an additional 700 shares during the period. Institutional investors own 32.98% of the company’s stock.

Insider Transactions at Kewaunee Scientific

In related news, VP Elizabeth D. Phillips sold 1,557 shares of the company’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $17.56, for a total value of $27,340.92. Following the completion of the transaction, the vice president now owns 14,035 shares of the company’s stock, valued at approximately $246,454.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 14.50% of the company’s stock.

Kewaunee Scientific Stock Performance

NASDAQ:KEQU opened at $18.01 on Tuesday. The stock has a 50-day simple moving average of $18.00 and a two-hundred day simple moving average of $16.64. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.61 and a current ratio of 2.11. Kewaunee Scientific Co. has a 52-week low of $14.56 and a 52-week high of $19.04. The firm has a market capitalization of $52.30 million, a PE ratio of 13.24 and a beta of 0.29.

Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings data on Thursday, August 31st. The technology company reported $0.86 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 10.53% and a net margin of 1.81%. The company had revenue of $49.84 million during the quarter.

Analysts Set New Price Targets

Separately, TheStreet raised shares of Kewaunee Scientific from a “c+” rating to a “b-” rating in a research report on Thursday, August 31st.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.